Table 3.

Trend of IgG and IgM in COVID-19 patients subjected to multiple serological tests.

ID Patient	Age	Sex	IgG (AU/mL)	IgM (AU/mL)	Days between Symptom Onset and Serological Test	Days between Serological Tests	Trend	Clinical Status
#901	73	M	27.7	NEG	35			Critical
			25.07	-	38	3	IgG ↓ 10%
#184	78	M	11.58	1.56	35			Severe
			6.78	1.05	42	7	IgG ↓ 41%, IgM ↓ 33%
			7.44	3.49	55	13	IgG ↑ 9%, IgM ↑ 232%
#199	43	M	4.64	-	14			Severe
			3.88	1.27	56	42	IgG ↓ 16%
#667	49	M	28.25	NEG	57			Severe
			55.19	1.04	112	55	IgG ↑ 95%, IgM +
#572	55	M	24.23	1.02	52			Mild
			23.76	NEG	118	66	IgG =, IgM −
#628	44	M	10.46	NEG	39			Mild
			9.29	NEG	82	43	IgG ↓ 12%
			9.29	NEG	83	1	IgG =
#1107	92	F	7.84	1.9	74			Mild
			3.18	1.45	93	19	IgG ↓ 60%, IgM ↓ 25%
#1618	72	F	NEG	2.78	−12			Mild
			4.27	2.88	18	30	IgG +, IgM =
#589	41	M	NEG	NEG	−2			Pauci-symptomatic
			6.07	3.23	58	60	IgG and IgM +
			5.49	3.25	61	3	IgG ↓ 10%, IgM =
			6.66	3.24	125	64	IgG ↑ 18%, IgM =
#834	39	F	6.01	NEG	71			Pauci-symptomatic
			5.07	NEG	169	98	IgG ↓ 15%
#1059	34	F	4.45	NEG	-			Asymptomatic
			3.29	NEG		20	IgG ↓ 25%
#1087	47	F	13.33	-	-			Asymptomatic
			17.89	NEG		32	IgG ↑ 34%
#1342	30	F	NEG	NEG	-			Asymptomatic
			NEG	2.18		3	IgM +
			NEG	NEG		7	IgM −
			NEG	NEG		68
#1563	22	F	2.93	NEG	-			Asymptomatic
			5.56	NEG		62	IgG ↑ 47%
#1781	58	F	4.10	1.11	-			Asymptomatic
			4.51	1.49		58	IgG ↑ 8%, IgM ↑ 25%
#1796	52	F	1.39	NEG	-			Asymptomatic
			NEG	NEG		102	IgG −

M: male; F: female; NEG: negative; ↓: decrease; ↑: increase; =: stable; +: become positive; −: become negative.